Eli Lilly and Company (BMV:LLY)
14,506
-297 (-2.01%)
At close: May 13, 2025, 2:00 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Glucagon |
Log In |
Log In |
Log In |
Log In |
Glucagon Growth |
Log In |
Log In |
Log In |
Log In |
Humalog |
Log In |
Log In |
Log In |
Log In |
Humalog Growth |
Log In |
Log In |
Log In |
Log In |
Humulin |
Log In |
Log In |
Log In |
Log In |
Humulin Growth |
Log In |
Log In |
Log In |
Log In |
Trajenta |
Log In |
Log In |
Log In |
Log In |
Trajenta Growth |
Log In |
Log In |
Log In |
Log In |
Oncology |
Log In |
Log In |
Log In |
Log In |
Oncology Growth |
Log In |
Log In |
Log In |
Log In |
Neuroscience |
Log In |
Log In |
Log In |
Log In |
Neuroscience Growth |
Log In |
Log In |
Log In |
Log In |
Other Product |
Log In |
Log In |
Log In |
Log In |
Other Product Growth |
Log In |
Log In |
Log In |
Log In |
Jardiance |
Log In |
Log In |
Log In |
Log In |
Jardiance Growth |
Log In |
Log In |
Log In |
Log In |
Trulicity |
Log In |
Log In |
Log In |
Log In |
Trulicity Growth |
Log In |
Log In |
Log In |
Log In |
Basaglar |
Log In |
Log In |
Log In |
Log In |
Basaglar Growth |
Log In |
Log In |
Log In |
Log In |
Other Cardiometabolic Health |
Log In |
Log In |
Log In |
Log In |
Other Cardiometabolic Health Growth |
Log In |
Log In |
Log In |
Log In |
Cardiometabolic Health |
Log In |
Log In |
Log In |
Log In |
Cardiometabolic Health Growth |
Log In |
Log In |
Log In |
Log In |
Immunology |
Log In |
Log In |
Log In |
Log In |
Immunology Growth |
Log In |
Log In |
Log In |
Log In |
Baqsimi |
Log In |
Log In |
Log In |
Log In |
Baqsimi Growth |
Log In |
Log In |
Log In |
Log In |
Mounjaro |
Log In |
Log In |
Log In |
Log In |
Mounjaro Growth |
Log In |
Log In |
Log In |
Log In |
Zepbound |
Log In |
Log In |
Log In |
Log In |
Zepbound Growth |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
US Revenue |
Log In |
Log In |
Log In |
Log In |
US Revenue Growth |
Log In |
Log In |
Log In |
Log In |
Europe |
Log In |
Log In |
Log In |
Log In |
Europe Growth |
Log In |
Log In |
Log In |
Log In |
Japan |
Log In |
Log In |
Log In |
Log In |
Japan Growth |
Log In |
Log In |
Log In |
Log In |
Other Foreign Countries |
Log In |
Log In |
Log In |
Log In |
Other Foreign Countries Growth |
Log In |
Log In |
Log In |
Log In |
China |
Log In |
Log In |
Log In |
Log In |
China Growth |
Log In |
Log In |
Log In |
Log In |
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Change due to Price |
Log In |
Log In |
Log In |
Log In |
Revenue Change due to Price Growth |
Log In |
Log In |
Log In |
Log In |
Revenue Change due to Volume |
Log In |
Log In |
Log In |
Log In |
Revenue Change due to Volume Growth |
Log In |
Log In |
Log In |
Log In |
Revenue Change due to FX |
Log In |
Log In |
Log In |
Log In |
Revenue Change due to FX Growth |
Log In |
Log In |
Log In |
Log In |